Добірка наукової літератури з теми "Chronic heart and renal failures"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Chronic heart and renal failures".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Chronic heart and renal failures"
El-Belbessi, Sami, Nachman Brautbar, Kenneth Anderson, Vito M. Campese, and Shaul G. Massry. "Effect of Chronic Renal Failure on Heart." American Journal of Nephrology 6, no. 5 (1986): 369–75. http://dx.doi.org/10.1159/000167193.
Повний текст джерелаParker, J., F. Valle, and D. Cherney. "RENAL OXYGEN CONSUMPTION IN CHRONIC HEART FAILURE." Canadian Journal of Cardiology 34, no. 10 (October 2018): S92—S93. http://dx.doi.org/10.1016/j.cjca.2018.07.478.
Повний текст джерелаHaffner, S. M., K. K. Gruber, G. Aldrete, P. A. Morales, M. P. Stern, and K. R. Tuttle. "Increased lipoprotein(a) concentrations in chronic renal failure." Journal of the American Society of Nephrology 3, no. 5 (November 1992): 1156–62. http://dx.doi.org/10.1681/asn.v351156.
Повний текст джерелаBoran, Mediha, M. Kamil Göl, Erol Şener, Oğuz Taşdemir, and Kemal Bayazit. "Open Heart Surgery in Patients with Chronic Renal Failure." Asian Cardiovascular and Thoracic Annals 3, no. 3-4 (September 1995): 112–16. http://dx.doi.org/10.1177/021849239500300405.
Повний текст джерелаVoronkov, L. G., A. V. Liashenko, N. A. Tkach, and L. P. Paraschenyuk. "Chronic heart failure as multimorbid state." Ukrainian Journal of Cardiology 26, no. 4 (October 8, 2019): 90–101. http://dx.doi.org/10.31928/1608-635x-2019.4.90101.
Повний текст джерелаКурлянская, Е. К. "Renal Denervation in Patients with Chronic Heart Failure." Кардиология в Беларуси, no. 4 (September 26, 2022): 456–68. http://dx.doi.org/10.34883/pi.2022.14.4.008.
Повний текст джерелаvan der Meer, P., and D. J. van Veldhuisen. "Anaemia and renal dysfunction in chronic heart failure." Heart 95, no. 21 (October 14, 2009): 1808–12. http://dx.doi.org/10.1136/hrt.2008.151258.
Повний текст джерелаWaldum, Bård, Arne S. Westheim, Leiv Sandvik, Berit Flønæs, Morten Grundtvig, Lars Gullestad, Torstein Hole, and Ingrid Os. "Renal Function in Outpatients With Chronic Heart Failure." Journal of Cardiac Failure 16, no. 5 (May 2010): 374–80. http://dx.doi.org/10.1016/j.cardfail.2010.01.001.
Повний текст джерелаOmar, Sabry, and Ahmed Zedan. "Cardiorenal syndrome." Southwest Respiratory and Critical Care Chronicles 1, no. 1 (January 30, 2013): 11. http://dx.doi.org/10.12746/swrccc.v1i1.24.
Повний текст джерелаUnic-Stojanovic, Dragana, Miroslav Milicic, Petar Vukovic, Srdjan Babic, and Miomir Jovic. "Heart surgery in patients on chronic dialysis." Medical review 66, no. 1-2 (2013): 64–69. http://dx.doi.org/10.2298/mpns1302064u.
Повний текст джерелаДисертації з теми "Chronic heart and renal failures"
He, Jiang, Michael Shlipak, Amanda Anderson, Jason A. Roy, Harold I. Feldman, Radhakrishna Reddy Kallem, Radhika Kanthety, et al. "Risk Factors for Heart Failure in Patients With Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study." WILEY, 2017. http://hdl.handle.net/10150/625054.
Повний текст джерелаBrunini, Tatiana Marlowe Cunha. "L-arginine-nitric oxide pathway in blood cells from chronic renal and heart failure patients." Thesis, University of Oxford, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.326115.
Повний текст джерелаMark, Patrick Barry. "Redefinition of uraemic cardiomyopathy with cardiac magnetic resonance imaging." Thesis, Connect to e-thesis, 2008. http://theses.gla.ac.uk/65/.
Повний текст джерелаPh.D. thesis submitted to the Faculty of Medicine, Division of Cardiovascular and Medical Sciences, University of Glasgow, 2007. Includes bibliographical references. Print version also available.
Coles, Andrew H. "Long-Term Survival and Prognostic Factors in Patients with Acute Decompensated Heart Failure According to Ejection Fraction Findings: A Population-Based Perspective: A Master Thesis." eScholarship@UMMS, 2014. https://escholarship.umassmed.edu/gsbs_diss/722.
Повний текст джерелаColes, Andrew H. "Long-Term Survival and Prognostic Factors in Patients with Acute Decompensated Heart Failure According to Ejection Fraction Findings: A Population-Based Perspective: A Master Thesis." eScholarship@UMMS, 2008. http://escholarship.umassmed.edu/gsbs_diss/722.
Повний текст джерелаGalil, Arise Garcia de Siqueira. "Prevalência de anemia e doença renal crônica em portadores de insuficiência cardíaca sistólica num ambulatório de hipertensos e diabéticos." Universidade Federal de Juiz de Fora (UFJF), 2008. https://repositorio.ufjf.br/jspui/handle/ufjf/2837.
Повний текст джерелаApproved for entry into archive by Adriana Oliveira (adriana.oliveira@ufjf.edu.br) on 2016-10-22T13:00:41Z (GMT) No. of bitstreams: 1 arisegarciadesiqueiragalil.pdf: 700408 bytes, checksum: bda59712c26407e09b49f3dd136c52b2 (MD5)
Made available in DSpace on 2016-10-22T13:00:41Z (GMT). No. of bitstreams: 1 arisegarciadesiqueiragalil.pdf: 700408 bytes, checksum: bda59712c26407e09b49f3dd136c52b2 (MD5) Previous issue date: 2008-02-15
Introdução: A insuficiência cardíaca (IC) tem alta morbimortalidade que decorre de fatores causais e refratariedade ao tratamento. A doença renal crônica (DRC) e a anemia têm se associado a pior prognóstico em pacientes com IC grave, especialmente os hospitalizados. Há, porém, poucos estudos que avaliem a prevalência e as conseqüências da DRC e da anemia em pacientes com IC acompanhados ambulatorialmente. Objetivos: Avaliar a prevalência da DRC e anemia e o impacto de desfechos cardiovasculares em portadores de IC sistólica estágios B e C. Pacientes e Métodos: Foram estudados pacientes adultos, com idade >18 anos e diagnóstico de IC sistólica e com fração de ejeção (EF) ≤45%, selecionados do ambulatório do Serviço de Hipertensão, Diabetes e Obesidade do SUS de Juiz de Fora e acompanhados por 12 meses. A anemia foi definida como hemoglobina <12,0g/dl nas mulheres e <13,0g/dl nos homens. A reserva de ferro foi considerada adequada quando índice de saturação da transferrina encontrava-se ≥20% e a ferritina ≥100ηg/dl. A filtração glomerular foi estimada pela fórmula do estudo MDRD e a DRC foi definida como proposto pelo K/DOQI da National Kidney Foundation americana. Considerou-se com desfechos cardiovasculares (CV) a ocorrência de hospitalização e/ou morte decorrente da IC. Os dados demográficos, de exame físico e laboratorial foram obtidos do prontuário dos pacientes. Resultados: Foram avaliados 83 pacientes, com idade média de 62,7±12 anos, sendo 56,6% do sexo feminino. A média da fração de ejeção (FE) foi de 37,8+7,9% e a maioria dos indivíduos (60,2%) estava no estágio C. A prevalência de anemia foi de 24,09%; 30,30% no estágio B e 20% no estágio C. A prevalência de DRC foi elevada, presente em 49,4% da amostra, 42,4% no estágio B da IC e 54% no estágio C. Todos os pacientes com anemia tinham reserva de ferro normal e 68,6% apresentavam DRC concomitante. Os desfechos CV ocorreram em 26,5% da amostra. Na estratificação dos pacientes nos estágios B e C da IC e presença ou não de DRC, evidenciou que 100% e 64,7% apresentaram desfechos, respectivamente. Na análise multivariada, após ajustes para fatores prognósticos no período basal, o diagnóstico de DRC aumentou em 3,6 vezes a possibilidade de desfechos (IC 95%1,04-12,67, p=0,04), enquanto os níveis mais elevados de sódio sérico (R 0,807, IC95%0,862-0,992, p=0,03) e da fração de ejeção (R 0,925, IC95% 0,862-0,942, p= 0,03) se mostraram protetores. Conclusão: Na coorte de pacientes estudada, composta de pacientes com IC estágios B e C, a ocorrência de anemia foi compatível com a observada em outros estudos e com tendência de se associar com menor filtração glomerular. A DRC foi prevalente e independentemente se associou a maior risco de hospitalizações e mortes secundárias à descompensação cardíaca, especialmente nos pacientes assintomáticos.
Introduction: Chronic heart failure (CHF) has a high morbidity and mortality which are consequent to etiologic factors and no response to treatment. Anemia and chronic kidney disease (CKD) have been associated to worse outcome in patients with severe hospitalized CHF. So far, there is few studies that assessed the prevalence and the consequences of anemia and CKD in outpatients with CHF. Aim: To study the prevalence of CKD and anemia and the impact of CV end points in patients with systolic CHF followed in an outpatient clinic. Methods: This is prospective cohort study, dealing with adult patients older than 18 years of age and diagnosis of systolic CHF and ejection fraction (EF) ≤45%, selected from the Hypertension, Diabetes and Obesity Outpatient Clinic of SUS of Juiz de Fora. Anemia was defined as hemoglobin <12,0g/dL in women and <13g/dL in men and women after the menopause. Normal iron store was defined when transferring saturation index was >20% and/or ferritin >100ηg/dL. The glomerular filtration rate was estimated from serum creatinine usinf the MDRD study formula, and CKD was defined as suggested by the K/DOQI of National Kidney Foundation. CV endpoints were defined as death or hospitalization due to CHF, in 12 months follow up. Demographic and clinical date were obtained from the patients’ charts. Results: Eight three patients were studied, the mean age was 62.7±12 years, and 56.6% were female. The EF was 37,8+7,9%, and the majority of the patients had stage C CHF (60,2%). The prevalence of anemia was 24,1%; 30,3% in stage B and 50% in stage C. CKD was diagnosed in 49.4% of the patients, 42,4% of the stage B and 54% in the stage C. All patients with anemia had normal iron storage, and 68,6% had concomitant CKD. Cardiovascular endpoints were observed in 26.5% of the patients. When the sample was stratified in stages B and C of CHF and presence or absence of CKD, it was found that 100% and 64.7% had CV endpoints, respectively. After adjustments for all other prognostic factors at baseline, it was observed that the diagnosis of CKD increased in 3.6 folds the hazard of CV endpoints (CI 95% 1,04-12,67, p=0,04), whereas higher ejection fraction (R 0,925, IC 95% 0,862-0,942, p= 0,03) and serum sodium (R 0,807, IC 95% 0,862-0,992, p=0,03) were protectors. Conclusion: In this cohort of outpatients with CHF stages B and C, the occurrence of anemia was low and frequently associated with concomitant CKD. On the other hand, CKD was prevalent and independently associated with heightened risk for hospitalization and death secondary of cardiovascular causes, mainly in asymptomatic patients.
Gatti, Márcio. "Variabilidade da freqüência cardíaca e seu valor prognóstico imediato em nefropatas crônicos submetidos à hemodiálise." Faculdade de Medicina de São José do Rio Preto, 2015. http://hdl.handle.net/tede/402.
Повний текст джерелаMade available in DSpace on 2018-02-27T14:13:48Z (GMT). No. of bitstreams: 1 marciogatti_dissert.pdf: 2240052 bytes, checksum: 38cfe0f95ee7d8c6d51f09ffe75f33ba (MD5) Previous issue date: 2015-11-17
Introduction: Chronic Renal Failure (CRF) is a metabolic syndrome resulting in progressive loss of ability to renal excretion. In advanced stages dialysis is necessary. The introduction of new technological advances in hemodialysis made this procedure safe and able to maintain patients' lives for long periods. However, in 30% of the hemodialysis, may occur some kind of complication. The heart rate variability (HRV) reveals information on the functional state of the autonomic nervous system and reflects the balance between the sympathetic and parasympathetic branches of the same. HRV analysis have been proposed as a component of the clinical evaluation for risk stratification of patients. HRV can be studied by linear methods, time domain and frequency and nonlinear methods in the field of chaos. Objective: Assess whether or not there is an association between lower HRV immediately preceding the hemodialysis and the occurrence of complications during or after the same period. Casuistic and Method: 44 unselected patients were included in the study, regardless of sex and age being 15 (34.1%) were female and 29 patients (65.9%) males, with 61.7 ± 14.5 years. Inclusion criteria were considered just the fact of having IRC, be in regular program of performing hemodialysis in the dialysis unit at Hospital de Base (HB) of São José do Rio Preto. The methodology consisted of the assessment of HRV in the time, frequency and chaos, using registration electrocardiographic time series with the aid of equipment Polar RS800CX for 20 minutes moments before initiating hemodialysis session. The 44 patients were followed throughout the dialysis period by verifying the occurrence of complications. Results: 35 patients (NC) had no complications during hemodialysis, while 9 patients (C) had complications, such as hypotension, hypoglycemia, and cramps. The results showed no association between lower HRV with the occurrence of complications during or after hemodialysis. But it was evident that the diabetic patients had a higher probability of complications, because it was the only variable that showed a statistically significant difference. Comparing the results of HRV in diabetic patients with nondiabetic patients, we found lower values for the variables that represent the sympathetic autonomic activity, such as SDNN, LF, SD2 and alpha 1. Conclusions: HRV in the time, frequency and chaos was not characterized as a predictor of the occurrence of complications during or after hemodialysis. However, in diabetic patients there is a significant reduction in the sympathetic component associated with the occurrence of complications, highlighting the possibility of using a simple, noninvasive method for determining prognosis by studying HRV.
Introdução: Insuficiência Renal Crônica (IRC) é uma síndrome metabólica decorrente de perda progressiva da capacidade de excreção renal. Em fases avançadas é necessário o tratamento dialítico. A introdução de novos avanços tecnológicos no tratamento hemodialítico tornou esse procedimento seguro e capaz de manter a vida dos pacientes por longos períodos. Entretanto, em 30% das sessões de hemodiálise, pode ocorrer algum tipo de complicação. A variabilidade da freqüência cardíaca (VFC) revela informações do estado funcional do sistema nervoso autônomo e reflete o balanço entre os ramos parassimpático e simpático do mesmo. Análises da VFC têm sido propostas como um componente da avaliação clínica para a estratificação do risco dos pacientes. A VFC pode ser estudada por meio de métodos lineares, no domínio do tempo e da frequência e métodos não lineares, no domínio do caos. Objetivo: Avaliar se há ou não associação entre menor VFC no período imediatamente precedente à realização de hemodiálise e a ocorrência de complicações durante ou logo após a mesma. Casuística e Método: Foram incluídos no estudo 44 pacientes não selecionados, independente do sexo e idade sendo 15 (34,1%) do sexo feminino e 29 (65,9%) do sexo masculino, com 61,7±14,5 anos. Os critérios de inclusão foram considerados apenas o fato de ser portador de IRC, estar em programa regular de realização de hemodiálise na Unidade de Terapia Dialítica do HB de São José do Rio Preto. A metodologia consistiu na avaliação da VFC nos domínios do tempo, frequência e caos, utilizando-se de registro de series temporais eletrocardiográficas com auxilio do equipamento Polar RS800CX, por 20 minutos instantes antes de iniciarem a sessão de hemodiálise. Os 44 pacientes foram acompanhados durante todo o período dialítico com a verificação da ocorrência de complicações. Resultados: 35 pacientes (NC) não tiveram complicações durante a hemodiálise, enquanto que 9 pacientes (C) apresentaram complicações, como hipotensão, hipoglicemia e câimbras. Os resultados obtidos mostraram que não houve associação entre uma menor VFC com a ocorrência de complicações durante ou logo após a hemodiálise. Porém foi evidente que os pacientes diabéticos apresentaram maior probabilidade de complicações, pois foi a única variável que apresentou diferença estatisticamente significativa. Comparando os resultados da VFC nos pacientes diabéticos com os não diabéticos, encontramos menores valores para as variáveis que representam a atividade autonômica simpática, como SDNN, LF, SD2 e alfa 1. Conclusões: A VFC nos domínios do tempo, freqüência e caos não se caracterizou como preditivo da ocorrência de complicações durante ou logo após a hemodiálise. Entretanto, em pacientes diabéticos há uma redução significante do componente simpático associado à ocorrência de complicações, ressaltando-se a possibilidade de utilização de um método simples e não invasivo para determinação de prognóstico por meio do estudo da VFC.
Ardito, Sabrina Queiroz. "Impacto da Insuficiência renal crônica associada à insuficiência Cardíaca Crônica Sistólica em pacientes com Cardiomiopatia Chagásica: Prevalência e Prognóstico." Faculdade de Medicina de São José do Rio Preto, 2011. http://bdtd.famerp.br/handle/tede/116.
Повний текст джерелаThis study aimed at determining the prevalence and the prognostic significance of chronic renal impairment in patients with chronic systolic heart failure secondary to Chagas cardiomyopathy. A total of 245 patients followed at the Cardiomyopathy Outpatient service from January, 2000 to December, 2008 with the diagnosis of chronic systolic heart failure secondary to Chagas cardiomyopathy were included. Chronic renal impairment was diagnosed in 42 (17%) patients. A Cox proportional hazards model was used to evaluate the role of chronic renal impairment as a prognostic index, and a Kaplan-Meier survival curve to study its association with all-cause mortality. Baseline characteristics of patients with and without chronic renal impairment were similar. Beta-Blocker therapy (Hazard ratio=0,42; 95% Confidence Interval 0,27 to 0,63, p value <0,005), left ventricular ejection fraction (Hazard Ratio=0,97; 95% Confidence Interval 0,95 to 0,99; p value=0,005), serum sodium levels (Hazard ratio=0,94; 95% Confidence Interval 0,90 to 0,98; p value=0,004), inotropic support (Hazard Ratio= 1,85; 95% Confidence Interval 1,21 to 2,64; p value= 0,03), and digoxin use (Hazard ratio=2,35; 95% Confidence Interval 1,15 to 4,81; p value=0,02) were independent predictors of all- cause mortality. Survival probability at 12, 24, 36, and 60 months was 74%, 60%, 52%, and 37%, respectively, in patients with chronic renal impairment, and 84%, 70%, 70%, and 35% ,respectively, in patients without (p>0,05). Chronic renal impairment has a low prevalence and no prognostic significance in patients with chronic systolic heart failure secondary to Chagas Cardiomyopathy.
Este estudo tem por objetivo determinar a prevalência e a significância prognóstica da disfunção renal crônica em pacientes com insuficiência cardíaca crônica sistólica secundária à cardiomiopatia chagásica. Duzentos e quarenta e cinco pacientes seguidos no Ambulatório de Cardiomiopatia de Janeiro de 2000 a Dezembro de 2008 com o diagnóstico de insuficiência cardíaca crônica secundária a cardiomiopatia Chagásica foram incluídos no estudo. Disfunção renal crônica foi diagnósticada em 42 (17%) pacientes. Um modelo proporcional de Cox foi usado para avaliar a evolução da disfunção renal crônica como um indice prognóstico, e uma curva de sobrevida de Kaplan-Meier para estudar sua associação com todas as causas de mortalidade. As características basais dos pacientes com e sem disfunção renal crônica foram semelhantes. Terapia com betabloqueador (Razão de Risco=0,42; Intervalo de Confiança 95% de 0,27 a 0,63, p<0,005)], fração de ejeção ventricular esquerda(Razão de Risco=0,97; Intervalo de Confiança 95% de 0,95 a 0,99; p=0,005), nível sérico de sódio(Razão de Risco=0,94; Intervalo de Confiança 95% de 0,90 a 0,98; p=0,004), suporte inotrópico(Razão de risco = 1,85; Intervalo de Confiança 95% de 1,21 a 2,64; p= 0,03) e uso de digoxina(Razão de Risco =2,35; Intervalo de Confiança 95% de 1,15 a 4,81; p=0,02) foram fatores de predição independentes de mortalidade geral. A probabilidade de sobrevida em 12, 24, 36, e 60 meses foi 74%, 60%, 52%, e 37%, respectivamente, em pacientes com disfunção renal crônica e 84%, 70%, 70% e 35%, respectivamente, em pacientes sem disfunção renal crônica(p>0,05). A disfunção renal crônica tem baixa prevalência e não tem significância prognóstica em pacientes com insuficiência cardíaca crônica sistólica secundária a cardiomiopatia chagásica.
Bosco-Lévy, Pauline. "Heart failure in France : chronic heart failure therapeutic management and risk of cardiac decompensation in real-life setting." Thesis, Bordeaux, 2019. http://www.theses.fr/2019BORD0348.
Повний текст джерелаIn France, around one million persons would be affected by heart failure (HF); there are nearly 70 000 deaths related to HF and more than 150 000 hospitalizations despite a well defined treatment management. These numbers should increase in the next years due in particular to the ageing of the population.The objective of this work was to study the use of the pharmacological treatments indicated in HF (beta-blocker, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, aldosterone antagonist, diuretics, digoxin, ivabradine) in real-world setting and to identify the clinical or pharmacological predictors associated with a new episode of cardiac decompensation.A first work has enabled to estimate the accuracy of French claims databases in identifying HF patients.A second study estimated that 17 to 37% HF patients were not exposed to any HF treatment in the year following an incident HF hospitalization.The third and fourth parts of this thesis showed that almost one forth of HF patients was rehospitalized within the 2 years following a first hospitalization. The main clinical predictors of rehospitalization were age, high blood pressure, atrial fibrillation and diabetes. The association found between bivalent iron use and HF rehospitalization underlines the importance of the risk related to anemia or iron deficiency in the occurrence of a cardiac exacerbation episode.These results allow to reconsider the treatment management of HF patients and highlight the need to reinforce the surveillance of patients with a highest risk of cardiac exacerbation
Mebrate, Yoseph. "Mathematical modelling of periodic breathing in chronic heart failure to design novel real-time dynamic therapy." Thesis, Imperial College London, 2014. http://hdl.handle.net/10044/1/51091.
Повний текст джерелаКниги з теми "Chronic heart and renal failures"
S, Slaughter Mark, ed. Cardiac surgery in chronic renal failure. Malden, Mass: Blackwell Futura, 2007.
Знайти повний текст джерелаS, Slaughter Mark, ed. Cardiac surgery in chronic renal failure. Malden, Mass: Blackwell Futura, 2007.
Знайти повний текст джерелаS, Slaughter Mark, ed. Cardiac surgery in chronic renal failure. Malden, Mass: Blackwell Futura, 2007.
Знайти повний текст джерелаV, Wizemann, Kramer W, and Schütterle G, eds. The heart in end-stage renal failure: Etiology, symptoms, and management of uremic heart disease. Basel: Karger, 1986.
Знайти повний текст джерелаS, Parfrey Patrick, and Harnett John D, eds. Cardiac dysfunction in chronic uremia. Boston: Kluwer Academic Publishers, 1992.
Знайти повний текст джерелаKeenan, Emma W. Kidney patients' wellness diet--tasty recipes: Low protein, low potassium, low sodium, and low fat diet : combined renal and triglyceride diet. Virginia Beach, Va: Grunwald and Radcliff, 1986.
Знайти повний текст джерелаSlaughter, Mark S. Cardiac Surgery in Chronic Renal Failure. Wiley & Sons, Incorporated, John, 2008.
Знайти повний текст джерелаSlaughter, Mark S. Cardiac Surgery in Chronic Renal Failure. Wiley & Sons, Incorporated, John, 2008.
Знайти повний текст джерелаSlaughter, Mark S. Cardiac Surgery in Chronic Renal Failure. Wiley & Sons, Limited, John, 2007.
Знайти повний текст джерелаBakris, George L. Kidney in Heart Failure. Springer London, Limited, 2012.
Знайти повний текст джерелаЧастини книг з теми "Chronic heart and renal failures"
Böhm, Michael, Sebastian Ewen, Ina Zivanovic, and Felix Mahfoud. "Renal Denervation for Chronic Heart Failure." In Updates in Hypertension and Cardiovascular Protection, 281–92. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-34141-5_18.
Повний текст джерелаRascher, W., and M. Bald. "Atrial Natriuretic Peptide and Chronic Renal Failure." In Endocrinology of the Heart, 112–17. Berlin, Heidelberg: Springer Berlin Heidelberg, 1989. http://dx.doi.org/10.1007/978-3-642-83858-3_14.
Повний текст джерелаSlaughter, Mark S. "Surgical Treatment of Valvular Heart Disease in End-Stage Renal Failure." In Cardiac Surgery in Chronic Renal Failure, 75–82. Oxford, UK: Blackwell Publishing Ltd, 2007. http://dx.doi.org/10.1002/9780470994931.ch5.
Повний текст джерелаKulick, D. L., and U. Elkayam. "Central and Renal Hemodynamic Effects of Diltiazem in Chronic Heart Failure." In Heart Failure Mechanisms and Management, 306–12. Berlin, Heidelberg: Springer Berlin Heidelberg, 1991. http://dx.doi.org/10.1007/978-3-642-58231-8_32.
Повний текст джерелаRostand, Stephen G., and Edwin A. Rutsky. "Ischemic Heart Disease in Chronic Renal Failure: Demography, Epidemiology, and Pathogenesis." In Cardiac Dysfunction in Chronic Uremia, 53–66. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3902-5_4.
Повний текст джерелаDamman, Kevin. "A Patient with Progressive Renal Insufficiency in Chronic Heart Failure with Reduced Ejection Fraction." In Cardiorenal Syndrome in Heart Failure, 75–87. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-21033-5_6.
Повний текст джерелаMüller-Wieland, D., J. Brandts, M. Verket, N. Marx, and K. Schütt. "Glycaemic Control in Diabetes." In Prevention and Treatment of Atherosclerosis, 47–71. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/164_2021_537.
Повний текст джерелаLevin, Adeera. "When does anemia impact the heart in chronic kidney disease?" In Renal Anemia, 37–47. Dordrecht: Springer Netherlands, 2002. http://dx.doi.org/10.1007/978-94-015-9998-6_5.
Повний текст джерелаSerai, Suraj D., and Meng Yin. "MR Elastography of the Abdomen: Basic Concepts." In Methods in Molecular Biology, 301–23. New York, NY: Springer US, 2021. http://dx.doi.org/10.1007/978-1-0716-0978-1_18.
Повний текст джерелаHouse, Andrew A., Claudio Ronco, and Charles A. Herzog. "Chronic Kidney Disease and Heart Failure – A Nephrologic Approach." In Chronic Renal Disease, 560–70. Elsevier, 2015. http://dx.doi.org/10.1016/b978-0-12-411602-3.00046-9.
Повний текст джерелаТези доповідей конференцій з теми "Chronic heart and renal failures"
Janssen, Daisy J. A., Martijn A. Spruit, Jos M. G. A. Schols, and Emiel F. M. Wouters. "Advance Care Planning In Patients With COPD, Chronic Heart Failure Or Chronic Renal Failure." In American Thoracic Society 2010 International Conference, May 14-19, 2010 • New Orleans. American Thoracic Society, 2010. http://dx.doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a4015.
Повний текст джерелаTran, Vinh Phuc, and Adel Ali Al-Jumaily. "Non-contact real-time estimation of intrapulmonary pressure and tidal volume for chronic heart failure patients." In 2016 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC). IEEE, 2016. http://dx.doi.org/10.1109/embc.2016.7591498.
Повний текст джерелаAranki, Daniel, Gregorij Kurillo, Posu Yan, David Liebovitz, and Ruzena Bajcsy. "Continuous, Real-Time, Tele-monitoring of Patients with Chronic Heart-Failure - Lessons Learned From a Pilot Study." In 9th International Conference on Body Area Networks. ICST, 2014. http://dx.doi.org/10.4108/icst.bodynets.2014.257036.
Повний текст джерела